Blood-Brain Chip Predicts Glioblastoma Treatment Response
Researchers at KAIST and partner institutions have developed a microfluidic chip that mimics the blood-brain barrier to predict how individual glioblastoma patients will respond to specific drugs. This technology addresses the challenge of patient-specific tumor environments, which often cause standard treatments to fail.
Even for the same brain tumor treated with the same anticancer drug, the effect can differ from patient to patient. A Korean research team has developed a chip that recreates a patient's own tumor cells together with the surrounding peritumoral vascular environment, making it possible to predict patient-specific treatment responses in advance.
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in